Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19103369.
- Also identified by DOI 10.1016/j.jaad.2008.07.057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Erlotinib, a specific epidermal growth factor receptor tyrosine kinase inhibitor, is used to treat various metastatic cancers. It is known to cause an acneiform rash. Herein, we report a case where the rash spared the previous radiotherapy field. A limitation of this study is that it is an anecdotal case report. Further research into the pathologic process of the rash is warranted to understand the reason for its absence in the irradiated skin.
Medical subject headings
- Folliculitis
- Protein Kinase Inhibitors
- Quinazolines
- Skin